Journal article · 2025

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

Francesca L. Celletti, Jeremy Farrar, Luz María de Regil

JAMA, 335(5), 434 · Published 1 December 2025 · DOI 10.1001/jama.2025.24288

View at the publisherCite this paper

In brief

“World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults” is a 2025 journal article by Francesca L. Celletti and 2 co-authors, published in JAMA. OpenAlex counts 195 citations as of 16 November 2026, which puts it in the top 5% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
195
Most cited in
2026 (192)
Field-weighted impact
76.20
References
13
Authors
3

Abstract

Importance: Obesity is a chronic, relapsing disease affecting over 1 billion people worldwide, driving substantial morbidity, mortality, and economic burden. Glucagon-like peptide-1 therapies (GLP-1 therapies) provide clinically meaningful weight loss and broad metabolic benefits. In response to Member State requests, the World Health Organization (WHO) has issued guidelines for adults living with obesity. Observations: The… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Celletti, F. L., Farrar, J., & de Regil, L. M. (2025). World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults. JAMA, 335(5), 434. https://doi.org/10.1001/jama.2025.24288

MLA 9

Celletti, Francesca L., et al. “World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults.” JAMA, vol. 335, no. 5, 2025, p. 434. https://doi.org/10.1001/jama.2025.24288.

Chicago

Celletti, Francesca L., Jeremy Farrar, and Luz María de Regil. 2025. “World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults.” JAMA 335 (5): 434. https://doi.org/10.1001/jama.2025.24288.

Harvard

Celletti, F. L., Farrar, J. and de Regil, L. M. (2025) ‘World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults’, JAMA, 335(5), p. 434. doi:10.1001/jama.2025.24288.

IEEE

F. L. Celletti, J. Farrar, and L. M. de Regil, “World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults,” JAMA, vol. 335, no. 5, p. 434, 2025, doi: 10.1001/jama.2025.24288.

BibTeX

@article{celletti2025world,
  title     = {{World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults}},
  author    = {Celletti, Francesca L. and Farrar, Jeremy and de Regil, Luz María},
  journal   = {JAMA},
  year      = {2025},
  volume    = {335},
  number    = {5},
  pages     = {434},
  doi       = {10.1001/jama.2025.24288},
  url       = {https://doi.org/10.1001/jama.2025.24288}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment

  • obesity
  • GLP-1 receptor agonists
  • weight loss
  • behavior therapy
  • obesity-related comorbidities
  • obesity as chronic disease
  • equitable access to treatment
  • health system preparedness

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Celletti, F. L., Farrar, J., & de Regil, L. M. (2025). World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults. JAMA, 335(5), 434. https://doi.org/10.1001/jama.2025.24288

How many times has this paper been cited?

195 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Francesca L. Celletti, Jeremy Farrar, Luz María de Regil.

What is the DOI of this paper?

10.1001/jama.2025.24288, permanently at https://doi.org/10.1001/jama.2025.24288. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.